Galatea Bio Attracts $25M Investment to Advance AI-Based Genomic Solutions

By James Dargan · 30 March 2025 · 1 min read

Galatea Bio, a Miami-based AI-powered genomic research and clinical testing company, has raised $25 million in funding to expand its clinico-genomics platform. The round included investments from F-Prime, Helios Digital Ventures, Digitalis Ventures, AME Cloud, CEI Ventures, Alexandria, Founders Collective, Stanford President’s Fund, and HBM Genomics.

Founded by CEO and President Carlos D. Bustamante, Ph.D., Galatea Bio integrates clinical genomics, a proprietary biobank, and advanced AI algorithms to accelerate precision medicine. The company focuses on diverse populations, refining genetic risk prediction, biomarker discovery, and clinical trial optimization.

Bustamante said the funding will support multi-modal data integration and AI-driven applications to improve diagnostic accuracy and drive breakthroughs across Mendelian and complex diseases.

Featured image. Credit: Galatea Bio

TopicsAI AI-Based Genomic Solutions AI-driven platform AI-powered genomic research capital markets clinical testing F-Prime funding funding round Galatea Bio

About the author

James Dargan

James Dargan is a writer and researcher at The AI Insider. His focus is on the AI startup ecosystem and he writes articles on the space that have a tone accessible to the average reader.

Galatea Bio Attracts $25M Investment to Advance AI-Based Genomic Solutions

Trending today

Anthropic’s Claude Designs More Efficient Quantum Circuits With Automated Feedback

Italy’s Fincantieri to Invest Nearly $100M in Robotics, Physical AI for Shipyards

Anthropic Details AI-Driven Workforce Shift and Commits 5% of Shares to Public Benefit Fund as Replit Moves Default to OpenAI

Dream Labs Raises $90M in Seed Funding to Build Foundation Models for Any Robot

Zap Surgical Raises $36M in Funding to Scale Non-Invasive Robotic Brain Surgery

Exclusives

South Korea’s AI G3 Strategy: Decoded

10 Switzerland-Based AI Scale-Ups You Need to Know in 2026

Why Crypto Could Be AI’s Payment Layer: BlackRock Sees Stablecoins Connecting Commerce and Compute

Why AI Predictions Often Get The Technology Right But The Timeline Wrong

10 CEE & Baltics-Based AI Scale-Ups You Need to Know in 2026

More in Business & Markets

Skyfall AI Unveils Frontier Engineering World Model SKY-001

Dream Labs Raises $90M in Seed Funding to Build Foundation Models for Any Robot

Canada’s Promise Robotics Signs Multi-Year Deal With US Homebuilder DR Horton for Robotic Homebuilding

Japan’s Shimizu Invests in Noble Machines to Develop Humanoid Robots for Construction

Galatea Bio Attracts $25M Investment to Advance AI-Based Genomic Solutions

Trending today

Anthropic’s Claude Designs More Efficient Quantum Circuits With Automated Feedback

Italy’s Fincantieri to Invest Nearly $100M in Robotics, Physical AI for Shipyards

Anthropic Details AI-Driven Workforce Shift and Commits 5% of Shares to Public Benefit Fund as Replit Moves Default to OpenAI

Dream Labs Raises $90M in Seed Funding to Build Foundation Models for Any Robot

Zap Surgical Raises $36M in Funding to Scale Non-Invasive Robotic Brain Surgery

Exclusives

South Korea’s AI G3 Strategy: Decoded

10 Switzerland-Based AI Scale-Ups You Need to Know in 2026

Why Crypto Could Be AI’s Payment Layer: BlackRock Sees Stablecoins Connecting Commerce and Compute

Why AI Predictions Often Get The Technology Right But The Timeline Wrong

10 CEE & Baltics-Based AI Scale-Ups You Need to Know in 2026

More in Business & Markets

Skyfall AI Unveils Frontier Engineering World Model SKY-001

Dream Labs Raises $90M in Seed Funding to Build Foundation Models for Any Robot

Canada’s Promise Robotics Signs Multi-Year Deal With US Homebuilder DR Horton for Robotic Homebuilding

Japan’s Shimizu Invests in Noble Machines to Develop Humanoid Robots for Construction

The AI economy, every weekday morning